Psychopharmacology in autism.

作者: Luke Y. Tsai

DOI: 10.1097/00006842-199909000-00008

关键词:

摘要: Autism is a neurobiological disorder. The core clinical features of autism include impairment in social interaction, impairments verbal and nonverbal communication, restricted, repetitive, stereotyped patterns behavior, interests, activities. often has coexisting neuropsychiatric disorders, including seizure attention deficit hyperactivity disorder, affective anxiety obsessive-compulsive Tourette No etiology-based treatment modality been developed to cure individuals with autism. However, comprehensive intervention, parental counseling, behavior modification, special education highly structured environment, sensory integration training, speech therapy, skill medication, demonstrated significant effects many Findings from preliminary studies major neurotransmitters other neurochemical agents strongly suggest that factors play role findings also provide the rationale for psychopharmacotherapy This article reviews systems related psychopharmacological research disorders. Clinical indications pharmacotherapy are described, uses various medications suggested. discusses new avenues investigation may lead development more effective medication treatments persons

参考文章(116)
Robert L. Findling, Max Wiznitzer, Kathleen Maxwell, An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacology Bulletin. ,vol. 33, pp. 155- 159 ,(1997)
A. Kennedy, T. Berney, P. Shattock, F. Rowell, Role of neuropeptides in autism and their relationships with classical neurotransmitters Brain dysfunction. ,vol. 3, pp. 328- 345 ,(1990)
Magda Campbell, Arthur M. Small, R. L. Foltz, L. D. Bluhm, P. B. Adams, Judith Shay, Nilda M. Gonzalez, Naltrexone plasma levels, clinical response and effect on weight in autistic children. Psychopharmacology Bulletin. ,vol. 30, pp. 203- 208 ,(1994)
Detlor J, Shaywitz Ba, Harcherik D, Leckman Jf, Young Jg, Cohen Dj, Clonidine in the treatment of Tourette syndrome: a review of data. Advances in Neurology. ,vol. 35, pp. 391- 401 ,(1982)
Cataldo Tirolo, Bianca Marchetti, Nuccio Testa, Matteo Cioni, Maria C. Morale, Francesco Gallo, Nunzio Batticane, Renato Scifo, Alfredo Nicolosi, Maria C. Quattropani, Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Annali dell'Istituto Superiore di Sanità. ,vol. 32, pp. 351- 359 ,(1996)
Larry W. Thompson, Cognitive-behavioral therapy and treatment for late-life depression. The Journal of Clinical Psychiatry. ,vol. 57, pp. 29- 31 ,(1996)
Scot E. Purdon, Wilson Lit, Alain Labelle, Barry D.W. Jones, Risperidone in the treatment of pervasive developmental disorder The Canadian Journal of Psychiatry. ,vol. 39, pp. 400- 405 ,(1994) , 10.1177/070674379403900703